29.7 C
New York
Thursday, June 4, 2026

Tag: journal

Thea Serves Its One Billionth Practice Question, Cementing Its Place as a Leader in AI-Powered Active Learning

ARLINGTON, Va., June 3, 2026 /PRNewswire/ -- In an era when millions of students turn to AI to have answers handed to them, Thea has...

The Largest IPO in History Is Weeks Away. James Altucher’s Free Presentation Explains Why This Moment Matters.

As SpaceX prepares to list on the Nasdaq in June, the early technology trend spotter walks through the story behind one of the most anticipated public offerings in years.
As SpaceX prepares to list on the Nasdaq in June, the early technology trend spotter walks through the story behind one of the most anticipated public offerings in years.

Wesco Ranks #195 in 2026 Fortune 500® List

PITTSBURGH, June 3, 2026 /PRNewswire/ -- Wesco International (NYSE: WCC), a leading provider of business-to-business distribution, logistics services and supply chain solutions, announces its inclusion...

New Research Revealed Effective Surgical Management Techniques for Gynecomastia in Asian Men, Resulting in High Patient Satisfaction

Between 2018 and 2023, Dr Ivan Puah treated over 550 cases, addressing unique challenges in Singapore's multi-ethnic population. His study included diverse case profiles....

James Altucher: Starlink Authorized to Deploy Thousands More Satellites.

James Altucher walks through what Starlink's expanding constellation signals about the company's future and why most investors haven't connected the dots.
James Altucher walks through what Starlink's expanding constellation signals about the company's future and why most investors haven't connected the dots.

Physicians Subjected to Unreliable ‘Lie-Detector’ Tests, according to the Journal of American Physicians and Surgeons

Though polygraph ("lie detector") tests are too unreliable to be admissible in court, physicians may be forced to undergo them in Physician Health Programs

Nutrition Business Journal Releases 2026 Supplement Business Report: U.S. Market Surges Toward $100 Billion Milestone

Nutrition Business Journal Releases 2026 Supplement Business Report, Comprehensive Industry Analysis Driving Growth in Dietary Supplements

Altucher Breaks Down What Happens Next For SpaceX

With a Nasdaq listing targeted for June 12, the longtime early stage technology investor walks through the timeline investors are watching.
With a Nasdaq listing targeted for June 12, the longtime early stage technology investor walks through the timeline investors are watching.

Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in Canada for Individuals Aged 12 and Older

Saint Herblain (France), August 18, 2025 Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that Health Canada has granted marketing authorization for its single-dose vaccine, IXCHIQ®, for the prevention of disease caused by the chikungunya virus in individuals aged 12 years and older. This announcement adds to the adult marketing authorization already received in Canada1 and complements the adolescent label extension received in Europe in April 20252.

BRBR LOSS ALERT: BellRing Brands, Inc. Investors with Losses are Reminded of the Ongoing Securities Fraud Investigation – Contact BFA Law (NYSE:BRBR)

BellRing Brands, Inc. investors that lost money are notified to contact BFA Law about its ongoing securities fraud class action investigation.

OpenEvidence creates the first AI in history to score a perfect 100% on the United States Medical Licensing Examination (USMLE)

MIAMI, Aug. 15, 2025 /PRNewswire/ -- Knowledge-based assessments remain a foundation of medical education. However, leveraging these resources for learning requires detailed and verifiable...

BestQool Announces Summer Promotion and Fall Refresh with New Logo and BQ60Pro Preview

Summer Appreciation Sales Offers 12% Off All Products NEW YORK, Aug. 15, 2025 /PRNewswire/ -- BestQool , a pioneer manufacturer of home-use red light therapy...

Breakthrough T1D-Authored Paper Paves the Way for Beta Cell Replacement Therapies on the Path to Cures for Type 1 Diabetes

Changes recommended in clinical trial design to include the voice of more people living with type 1 diabetes in evaluating therapy benefits NEW YORK, Aug....

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsJournal